175 related articles for article (PubMed ID: 24339176)
1. Generation of a mouse line harboring a Bi-transgene expressing luciferase and tamoxifen-activatable creER(T2) recombinase in cartilage.
Lo Cascio L; Liu K; Nakamura H; Chu G; Lim NH; Chanalaris A; Saklatvala J; Nagase H; Bou-Gharios G
Genesis; 2014 Feb; 52(2):110-9. PubMed ID: 24339176
[TBL] [Abstract][Full Text] [Related]
2. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage.
Henry SP; Jang CW; Deng JM; Zhang Z; Behringer RR; de Crombrugghe B
Genesis; 2009 Dec; 47(12):805-14. PubMed ID: 19830818
[TBL] [Abstract][Full Text] [Related]
3. Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse.
Mailhiot SE; Zignego DL; Prigge JR; Wardwell ER; Schmidt EE; June RK
PLoS One; 2015; 10(7):e0130564. PubMed ID: 26151638
[TBL] [Abstract][Full Text] [Related]
4. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase.
Chen M; Lichtler AC; Sheu TJ; Xie C; Zhang X; O'Keefe RJ; Chen D
Genesis; 2007 Jan; 45(1):44-50. PubMed ID: 17211877
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
[TBL] [Abstract][Full Text] [Related]
6. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
Xu J; Yao G; Ru Y; Xie S
Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
[TBL] [Abstract][Full Text] [Related]
7. High-fidelity
Ackermann AM; Zhang J; Heller A; Briker A; Kaestner KH
Mol Metab; 2017 Mar; 6(3):236-244. PubMed ID: 28271030
[TBL] [Abstract][Full Text] [Related]
8. Inducible site-specific recombination in neural stem/progenitor cells.
Chen J; Kwon CH; Lin L; Li Y; Parada LF
Genesis; 2009 Feb; 47(2):122-31. PubMed ID: 19117051
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-inducible Cre-recombination in articular chondrocytes of adult Col2a1-CreER(T2) transgenic mice.
Zhu M; Chen M; Lichtler AC; O'Keefe RJ; Chen D
Osteoarthritis Cartilage; 2008 Jan; 16(1):129-30. PubMed ID: 17888690
[TBL] [Abstract][Full Text] [Related]
11. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
[TBL] [Abstract][Full Text] [Related]
12. Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells.
Sandhu U; Cebula M; Behme S; Riemer P; Wodarczyk C; Metzger D; Reimann J; Schirmbeck R; Hauser H; Wirth D
Nucleic Acids Res; 2011 Jan; 39(1):e1. PubMed ID: 20935052
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-inducible NaV1.8-CreERT2 recombinase activity in nociceptive neurons of dorsal root ganglia.
Zhao J; Nassar MA; Gavazzi I; Wood JN
Genesis; 2006 Aug; 44(8):364-71. PubMed ID: 16850455
[TBL] [Abstract][Full Text] [Related]
14. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
[TBL] [Abstract][Full Text] [Related]
15. Dwarfism in homozygous Agc1
Rashid H; Chen H; Hassan Q; Javed A
Genesis; 2017 Oct; 55(10):. PubMed ID: 28921880
[TBL] [Abstract][Full Text] [Related]
16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
17. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
[TBL] [Abstract][Full Text] [Related]
19. High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly.
Forni PE; Scuoppo C; Imayoshi I; Taulli R; Dastrù W; Sala V; Betz UA; Muzzi P; Martinuzzi D; Vercelli AE; Kageyama R; Ponzetto C
J Neurosci; 2006 Sep; 26(37):9593-602. PubMed ID: 16971543
[TBL] [Abstract][Full Text] [Related]
20. Efficient in vivo doxycycline and cre recombinase-mediated inducible transgene activation in the murine trabecular meshwork.
Liu P; Fu X; Johnson RL
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):969-74. PubMed ID: 21051732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
